-
Penguin Solutions Q3 Preview: Revenue May Slip, But 1 Segment Could Surprise
Monday, July 7, 2025 - 11:25am | 337As Penguin Solutions (NASDAQ:PENG) prepares to unveil its fiscal third-quarter results on Tuesday, market watchers are bracing for a pivotal moment that could shape the company’s trajectory for the remainder of the year. The company is likely to report its results broadly in line with...
-
Micron Impresses Wall Street With Strong Q3 Earnings, 'Continued Strength In AI Data Center'
Thursday, June 26, 2025 - 1:02pm | 918Micron Technology Inc (NASDAQ:MU) shares fell Thursday in early trading, despite the company on Wednesday reporting upbeat fiscal third-quarter earnings. The announcement came amid an exciting earnings season. Here are some key analyst takeaways. KeyBanc Capital Markets On Micron Technology Analyst...
-
Why General Mills' Surprise Pet Win Isn't Calming Investor Jitters
Thursday, June 26, 2025 - 12:53pm | 455Shares of General Mills Inc. (NYSE:GIS) remained under pressure on Thursday, despite the company’s upbeat fiscal fourth-quarter earnings report on Wednesday. The announcement came amid an exciting earnings season. Here are some key analyst takeaways. RBC Capital Markets On General Mills...
-
Paychex Faces Growth Gap: Can It Deliver On 2026 Targets?
Thursday, June 26, 2025 - 11:00am | 298The primary challenge in Paychex Inc.'s (NASDAQ:PAYX) latest results and guidance is reconciling the fiscal fourth quarter's 3% year-on-year organic revenue growth with the 5% guidance for fiscal 2026, according to Stifel. The Paychex Analyst: Analyst David Grossman maintained a Hold rating, while...
-
FedEx Analysts Cut Estimates After Company Withholds Full-Year 2026 Guidance For 'First Time Since 2020'
Wednesday, June 25, 2025 - 12:06pm | 562Shares of FedEx Corp (NYSE:FDX) were down Wednesday, despite the company reporting upbeat fiscal fourth-quarter results on Tuesday. The announcement came amid an exciting earnings season. Here are some key analyst takeaways. BofA Securities On FedEx Analyst Ken Hoexter reiterated a Buy rating,...
-
Carnival's Booking Surge Has Wall Street Talking 2026 Already
Wednesday, June 25, 2025 - 11:31am | 435Shares of Carnival Corp (NYSE:CCL) were trading lower on Wednesday, despite the company on Tuesday reporting upbeat fiscal second-quarter results. The announcement came amid an exciting earnings season. Here are some key analyst takeaways. Goldman Sachs On Carnival Analyst Lizzie Dove maintained a...
-
Semtech Slides Despite Record Q1 Sales: 4 Analysts Maintain Ratings
Wednesday, May 28, 2025 - 1:27pm | 574Shares of Semtech Corp (NASDAQ:SMTC) were down 5.8% at last check on Wednesday, despite the company’s upbeat first-quarter results. Here are some key analyst takeaways. Stifel analyst Tore Svanberg reiterated a Buy rating, while raising the price target from $42 to $45. Piper Sandler analyst...
-
Okta Posts Q1 Beat, Outlook Hit By Heightened Macro Uncertainty, Analysts Revise Price Target
Wednesday, May 28, 2025 - 12:25pm | 1386Shares of Okta Inc (NASDAQ:OKTA) tanked in early trading on Wednesday despite the company’s upbeat quarterly results on Tuesday. Here are some key analyst takeaways. Guggenheim Securities On Okta Analyst John DiFucci reiterated a Buy rating while reducing the price target from $140 to $138....
-
Workday: Solid Q1 Revenue, Earnings Beat, Stock Gets Punished For Cautious Guidance — These Analysts Revise Price Target
Friday, May 23, 2025 - 12:42pm | 1359Workday Inc (NASDAQ:WDAY) tanked after the company on Thursday reported its fiscal first-quarter results. The announcement came amid an exciting earnings season. Here are some key analyst takeaways. KeyBanc Capital Markets On Workday Analyst Jason Celino reiterated an Overweight rating, while...
-
Snowflake Pops After Solid Quarter: Analysts See Strength In AI, New Workloads
Thursday, May 22, 2025 - 1:11pm | 1016Shares of Snowflake Inc (NYSE:SNOW) rallied after the company Wednesday reported its first-quarter results. The announcement came amid an exciting earnings season. Here are some key analyst takeaways. Piper Sandler On Snowflake Analyst Brent Bracelin reiterated an Overweight rating, while raising...
-
Home Depot Posts Q3 Earnings Miss, But Accelerating Comp Sales Turns Analyst Bullish
Wednesday, May 21, 2025 - 12:13pm | 580Home Depot Inc (NYSE:HD) shares remained volatile after the company on Tuesday reported its first-quarter results. The announcement came amid an exciting earnings season. Here are some key analyst takeaways. Stifel On Home Depot Analyst Andrew Carter upgraded the rating from Hold to Buy, while...
-
Under Armour Finds No Major Surprises In Q4, Analysts Cut Price Target
Wednesday, May 14, 2025 - 12:21pm | 490Shares of Under Armour Inc (NYSE:UAA) were declining in early trading on Wednesday, after the company Tuesday reported its fiscal fourth-quarter results. Here are some key analyst takeaways. Truist Securities analyst Joseph Civello reaffirmed a Buy rating, while reducing the price target from $9...
-
Tesla Stock Faces Demand, Political, Tariff Pressure: Why Analysts Focus On 'Multiple Generational Growth Drivers'
Wednesday, April 23, 2025 - 12:36pm | 1170Tesla Inc (NASDAQ:TSLA) analysts are cautious on the short-term outlook of the electric vehicle company after it missed revenue and earnings per share estimates in the first quarter. The Tesla Analysts: Truist Securities analyst William Stein maintained a Hold rating on Tesla with a $280 price...
-
Wall Street Sours On Chipotle: Here Are ETFs Caught In The Crossfire
Tuesday, April 15, 2025 - 2:51pm | 891Chipotle Mexican Grill Inc. (NYSE:CMG) finds itself in the spotlight again as some Wall Street analysts lowered their price targets prior to the company’s first-quarter earnings release on April 23. These changes are not only important to Chipotle shareholders but also to a small group of...
-
Crinetics Pharmaceuticals Analyst Sees Around 70% Upside For Stock, Cites More Investor Interest In Endocrinology
Tuesday, March 25, 2025 - 2:49pm | 479Stifel initiated coverage on Monday on Crinetics Pharmaceuticals Inc (NASDAQ:CRNX), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for endocrine diseases and endocrine-related tumors. Crinetics’ lead development...